TY - JOUR
T1 - Is the internal thoracic artery the conduit of choice to replace a stenotic vein graft?
AU - Navia, Daniel
AU - Cosgrove, Delos M.
AU - Lytle, Bruce W.
AU - Taylor, Paul C.
AU - McCarthy, Patrick M.
AU - Stewart, Robert W.
AU - Rosenkranz, Eliot R.
AU - Loop, Floyd D.
PY - 1994/1
Y1 - 1994/1
N2 - Reoperative coronary artery bypass grafting secondary to saphenous vein graft (SVG) stenosis is a mushrooming problem. The internal thoracic artery graft (ITA) provides superior Long-term patency, but its flow is limited and may be inadequate to meet large myncardial demands. To evaluate the efficacy of the ITA as a replacement conduit for a stenotic SVG, 387 consecutive patients undergoing reoperative bypass grafting from 1985 to 1990 with a stenotic SVG to a totally obstructed left anterior descending coronary artery (LAD) were analyzed. The patients were divided into four groups according to the management of the previously placed SVG. Group I (n = 155) underwent graft replacement with a new SVG. Group II (n = 90) received an ITA with the old SVG left intact. In group III (n = 37), an ITA was placed to the LAD with an SVG to the diagonal (old graft interrupted). Group IV (n = 104) had an ITA only to the LAD (old graft interrupted). There were 14 deaths (3.6%). Mortality rate was 7.9% for group IV and 2.1% for groups I through III (p = 0.01). Multivariate analyses identified advancing age (p = 0.01), ITA only (p = 0.01), and female sex (p = 0.04) as independent predictors of operative mortality. Evidence of hypoperfusion in the distribution of the LAD was present in 19 patients, all of whom were in group IV (18.9%). Predictors of hypoperfusion were moderate/severe left ventricular function (p = 0.02) and ITA to the LAD with interruption of the old graft (p = 0.0001). Hypoperfusion syndrome was treated with a new SVG to the LAD in 11 patients, and all but 1 survived; 8 were treated with an intraaortic balloon pump, for a 63% mortality (p = 0.01). We conclude that replacing a stenotic SVG to a totally occluded LAD with an ITA is associated with increased mortality and increased incidence of hypoperfusion syndrome. Hypoperfusion syndrome is best treated with supplemental vein grafting.
AB - Reoperative coronary artery bypass grafting secondary to saphenous vein graft (SVG) stenosis is a mushrooming problem. The internal thoracic artery graft (ITA) provides superior Long-term patency, but its flow is limited and may be inadequate to meet large myncardial demands. To evaluate the efficacy of the ITA as a replacement conduit for a stenotic SVG, 387 consecutive patients undergoing reoperative bypass grafting from 1985 to 1990 with a stenotic SVG to a totally obstructed left anterior descending coronary artery (LAD) were analyzed. The patients were divided into four groups according to the management of the previously placed SVG. Group I (n = 155) underwent graft replacement with a new SVG. Group II (n = 90) received an ITA with the old SVG left intact. In group III (n = 37), an ITA was placed to the LAD with an SVG to the diagonal (old graft interrupted). Group IV (n = 104) had an ITA only to the LAD (old graft interrupted). There were 14 deaths (3.6%). Mortality rate was 7.9% for group IV and 2.1% for groups I through III (p = 0.01). Multivariate analyses identified advancing age (p = 0.01), ITA only (p = 0.01), and female sex (p = 0.04) as independent predictors of operative mortality. Evidence of hypoperfusion in the distribution of the LAD was present in 19 patients, all of whom were in group IV (18.9%). Predictors of hypoperfusion were moderate/severe left ventricular function (p = 0.02) and ITA to the LAD with interruption of the old graft (p = 0.0001). Hypoperfusion syndrome was treated with a new SVG to the LAD in 11 patients, and all but 1 survived; 8 were treated with an intraaortic balloon pump, for a 63% mortality (p = 0.01). We conclude that replacing a stenotic SVG to a totally occluded LAD with an ITA is associated with increased mortality and increased incidence of hypoperfusion syndrome. Hypoperfusion syndrome is best treated with supplemental vein grafting.
UR - http://www.scopus.com/inward/record.url?scp=0028012768&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028012768&partnerID=8YFLogxK
U2 - 10.1016/0003-4975(94)90362-X
DO - 10.1016/0003-4975(94)90362-X
M3 - Article
C2 - 7904147
AN - SCOPUS:0028012768
SN - 0003-4975
VL - 57
SP - 40
EP - 44
JO - The Annals of thoracic surgery
JF - The Annals of thoracic surgery
IS - 1
ER -